Age (mean) | 58 years (range 31 – 90 years) |
---|---|
Sex | 240 men, 68 women |
Follow-up (mean) | 64 months (range 4 – 181 months) |
T stadium | 135 T1 tumours |
125 T2 tumours | |
15 T3 tumours | |
33 T2 tumours | |
N stadium | 212 N0 lymph node negative |
57 N1 lymph node positive carcinoma | |
39 N2 lymph node positive carcinoma | |
Grading | 54 well differentiated tumours (G1) |
214 moderately differentiated tumours (G2) | |
40 weakly differentiated tumours (G3) |